Immunohistochemical evidences of anticancer actions of metformin with other repurposed drug combinations and correlation with hamster fibrosarcoma tumor size Scientific paper

Main Article Content

Jovan K. Popović
https://orcid.org/0000-0001-7880-0874
Dušıca J. Popovıć
https://orcid.org/0000-0001-7880-0874
Kosta J. Popovıć
https://orcid.org/0000-0001-7895-9009
Dejan Mıljkovıć
https://orcid.org/0000-0002-7739-5202
Dušan Laloševıć
https://orcid.org/0000-0002-0760-9180
Zana Dolićanin
https://orcid.org/0000-0003-0457-3087
Ivan Čapo
https://orcid.org/0000-0001-7531-5099

Abstract

The aim was to detect and correlate anticancer effects of metformin in combinations with other repurposed drugs, already registered for other indic­ations, which may be immediately applied and clinically investigated in onco­logy, reducing the time and cost of research for new cancer treatments. Immu­nohistochemistry was performed for tumors treated by dual drug combinations containing metformin with deoxycholic acid, caffeine, itraconazole, nitrogly­cerin, disulfiram or diclofenac. The drugs were applied in Syrian golden ham­sters (6 animals per group) with the inoculated BHK21/C13 fibrosarcoma in doses equivalent to usual human doses, <50 % LD50. The anticancer effects were assessed by: p53 (mutational status); Ki-67 and PCNA (tumor proli­fer­ation); CD34 and CD31 (neoangiogenesis); GLUT1 (glucose metabolism); iNOS (NO metabolism); COX4, Cytochrome C and caspase 3 (apoptosis); immunohistochemical markers. Also, biophysical characteristics of fibrosar­coma, animal blood samples and the toxicity on main organs were analyzed. Treatments significantly (P < 0.05) reduced mutational status, tumor prolifer­ation, neoangiogenesis, glucose metabolism, NO metabolism and modulated apoptosis, in correlation with tumor size, without toxicity and influence on bio­chemical blood and hematological tests. The administration of metformin in two-drug combination with deoxycholic acid, caffeine, itraconazole, nitrogly­cerin, disulfiram or diclofenac may be recommended for further clinical inves­tigations in oncology.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Article Details

How to Cite
[1]
J. Popović, “Immunohistochemical evidences of anticancer actions of metformin with other repurposed drug combinations and correlation with hamster fibrosarcoma tumor size: Scientific paper”, J. Serb. Chem. Soc., vol. 89, no. 5, pp. 643–656, May 2024.
Section
15 years of Professor Emeritus UNS
Author Biographies

Jovan K. Popović, University of Novi Sad, Faculty of Medicine, Department of Pharmacology, Toxicology and Clinical Pharmacology, Novi Sad, Serbia

Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia

Dušıca J. Popovıć, Department of Biomedical Sciences, State University of Novi Pazar, Vuka Karadžića 9, 36300 Novi Pazar, Serbia

Department of Biomedical Sciences, State University of Novi Pazar, Novi Pazar, Serbia

Kosta J. Popovıć, Department of Pharmacy, Faculty of Medicine, University of Novi Sad, Hajduk Veljkova 3, 21000 Novi Sad, Serbia

Department of Pharmacy, Faculty of Medicine, University of Novi Sad

Dejan Mıljkovıć, Department of Histology and Embryology, Faculty of Medicine, University of Novi Sad, Hajduk Veljkova 3, 21000 Novi Sad, Serbia

Department of Histology and Embryology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia

Dušan Laloševıć, Department of Histology and Embryology, Faculty of Medicine, University of Novi Sad, Hajduk Veljkova 3, 21000 Novi Sad, Serbia

Department of Histology and Embryology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia

Zana Dolićanin, Department of Biomedical Sciences, State University of Novi Pazar, Vuka Karadžića 9, 36300 Novi Pazar, Serbia

Department of Biomedical Sciences, State University of Novi Pazar, Novi Pazar, Serbia

Ivan Čapo, Department of Histology and Embryology, Faculty of Medicine, University of Novi Sad, Hajduk Veljkova 3, 21000 Novi Sad, Serbia

Department of Histology and Embryology, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia

Funding data

References

D. Verzella, A. Pescatore, D. Capece, D. Vecchiotti, M. V. Ursini, G. Franzoso, E. Alesse, F. Zazzeroni, Cell Death Dis. 11 (2020) 210 (https://doi.org/10.1038/s41419-020-2399-y)

L. Li, T. Wang, M. Hu, Y. Zhang, H. Chen, L. Xu, Front. Oncol. 10 (2020) 1605 (https://doi.org/10.3389/fonc.2020.01605)

L. Ma, J. Wei, J. Wan, W. Wang, L. Wang, Y. Yuan, Z. Yang, X. Liu, L. Ming, J. Exp. Clin. Cancer. Res. 38 (2019) 77 (https://doi.org/10.1186/s13046-019-1090-6)

C. C. Lu, J. H. Chiang, F. J. Tsai, Y. M. Hsu, Y. N. Juan, J. S. Yang, H. Y. Chiu, Int. J. Oncol. 54 (2019) 1271 (https://doi.org/10.3892/ijo.2019.4704)

J. Yang, J. Wei, Y. Wu, Z. Wang, Y. Guo, P. Lee, X. Li, Oncogenesis 4 (2015) e158 (https://doi.org/10.1038/oncsis.2015.18)

Z. Wu, Y. Lü, B. Wang, C. Liu, Z. R.Wang, World J Gastroenterol. 9 (2003) 2759 (http://dx.doi.org/10.3748/wjg.v9.i12.2759)

J. S. Pyo, Y. S. Ko, G. Kang, D. H. Kim, W. H. Kim, B. L. Lee, J. H. Sohn. J. Cancer Res. Clin. Oncol. 141 (2015) 1181 (https://doi.org/10.1007/s00432-014-1890-1)

J. P. Phelan, F. J. Reen, N. Dunphy, R. O'Connor, F. O'Gara, BMC Cancer 16 (2016) 476 (https://doi.org/10.1186/s12885-016-2528-2)

S. Yui, R. Kanamoto, T. Saeki, Nutr. Cancer 60 (2008) 91 (https://doi.org/10.1080/01635580701525893)

J. Ignacio Barrasa, N. Olmo, P. Pérez-Ramos, A. Santiago-Gómez, E. Lecona, J. Turnay, M. Antonia Lizarbe, Apoptosis 16 (2011) 1054 (https://doi.org/10.1007/s10495-011-0633-x)

H. B. Yang, W. Song, M. D. Cheng, H. F. Fan, X. Gu, Y. Qiao, X. Lu, R. H. Yu, L. Y. Chen, Mol. Med. Rep. 11 (2015) 2749 (https://doi.org/10.3892/mmr.2014.3004)

P. M. Rodrigues, M. B. Afonso, A. L. Simão, P. M. Borralho, C. M. P. Rodrigues, R. E. Castro, Sci. Rep. 5 (2015) 17528 (https://doi.org/10.1038/srep17528); Erratum in: Sci. Rep. 6 (2016) 27828 (https://doi.org/10.1038/srep27828)

M. Hałas, M. Izdebska, A. Klimaszewska-Wiśniewska, M. Gagat, D. Radciniewska, A. Glińska, K. Gizler, E. Bielińska, A. Grzanka, Open Life Sci. 9 (2014) 727 (https://doi.org/10.2478/s11535-014-0315-0)

E. D. Osarieme, D. T. Modupe, O. P.Oluchukwu, Arch. Clin. Biomed. Res. 3 (2019) 326 (https://doi.org/10.26502/acbr.50170077)

H. Tsubamoto, T. Ueda, K. Inoue, K. Sakata, H. Shibahara, T. Sonoda, Oncol. Lett. 14 (2017) 1240 (https://doi.org/10.3892/ol.2017.6325)

M. D. Navarro-Martínez, J. Cabezas-Herrera, J. N. Rodríguez-López, Int. J. Antimicrob. Agents 28 (2006) 560 (https://doi.org/10.1016/j.ijantimicag.2006.07.012)

C. L. Li, Z. X. Fang, Z. Wu, Y. Y. Hou, H. T. Wu, J. Liu, Biomed. Pharmacother. 154 (2022) 113616 (https://doi.org/10.1016/j.biopha.2022.113616)

J. Mintz, A. Vedenko, O. Rosete, K. Shah, G. Goldstein, J. M. Hare, R. Ramasamy, H. Arora, Vaccines 9 (2021) 94 (https://doi.org/10.3390/vaccines9020094)

A. Garcia, G.Tisman, J. Clin. Oncol. 28 (2010) e19 (https://doi.org/10.1200/jco.2009.25.7857)

M. A. Erkurt, İ. Aydoğdu, N. Bayraktar, İ. Kuku, E. Kaya, Turk. J. Hematol. 26 (2009) 197 (https://pubmed.ncbi.nlm.nih.gov/27265632/)

P. Pradhan, J. Vector. Borne. Dis. 46 (2009) 100 (https://pubmed.ncbi.nlm.nih.gov/19502689/)

V. Sukhatme, G. Bouche, L. Meheus, V. P. Sukhatme, P. Pantziarka, Ecancer 9 (2015) 568 (https://doi.org/10.3332/ecancer.2015.568)

B. Xu, S. Wang, R. Li, K. Chen, L. He, M. Deng, V. Kannappan, J. Zha, H. Dong, W. Wang, Cell. Death. Dis. 8 (2017) e2797 (https://doi.org/10.1038/cddis.2017.176)

O. Celik, A. Ersahin, M. Acet, N. Celik, Y. Baykus, R. Deniz, E. Ozerol, I. Ozerol, Eur. Rev. Med. Pharmacol. Sci. 20 (2016) 4380 (https://pubmed.ncbi.nlm.nih.gov/27831632/)

J. Zha, F. Chen, H. Dong, P. Shi, Y. Yao, Y. Zhang, R. Li, S. Wang, P. Li, W. Wang, B Xu, J. Transl. Med. 12 (2014) 163 (https://doi.org/10.1186/1479-5876-12-163)

M. A. Westhoff, S. Zhou, L. Nonnenmacher, G. Karpel-Massler, C. Jennewein, M. Schneider, M. E. Halatsch, N. O. Carragher, B. Baumann, A. Krause, T. Simmet, M. G. Bachem, C. R. Wirtz, K. M Debatin, Mol. Cancer. Res. 11 (2013) 1611 (https://doi.org/10.1158/1541-7786.mcr-13-0435-t)

W. Wang, H. L. McLeod, J. Cassidy, Int. J. Cancer. 104 (2003) 504 (https://doi.org/10.1002/ijc.10972)

K. Butcher, V. Kannappan, R. S. Kilari, M. R. Morris, C. McConville, A. L. Armesilla, W. Wang, BMC Cancer 18 (2018) 753 (https://doi.org/10.1186/s12885-018-4617-x)

J. Zhang, K. Pu, S. Bai, Y. Peng, F. Li, R. Ji, Q. Guo, W. Sun, Y. Wang, J. Int. Med. Res. 48 (2020) 300060520925996 (https://doi.org/10.1177/0300060520925996)

B. Herpers, S. Wink, L. Fredriksson, Z. Di, G. Hendriks, H. Vrieling, H. de Bont, B. van de Water, Arch. Toxicol. 90 (2016) 1163 (https://doi.org/10.1007/s00204-015-1536-3)

L. Fredriksson, B. Herpers, G. Benedetti, Q. Matadin, J. C. Puigvert, H. de Bont, S. Dragovic, N. P. Vermeulen, J. N. Commandeur, E. Danen, M. de Graauw, B. van de Water, Hepatology 53 (2011) 2027 (https://doi.org/10.1002/hep.24314)

Y. Takada, A. Bhardwaj, P. D. Potdar, B. Aggarwal, Oncogene 23 (2004) 9247 (https://doi.org/10.1038/sj.onc.1208169)

A. M. Cimpean, D. Lalošević, V. Lalošević, P. Banović, M. Raica, O. A. Mederle, In Vivo 32 (2018): 791 (https://doi.org/10.21873/invivo.11309)

G. Toffoli, C. Doglioni, , C. Cernigoi, S. Frustaci, T. Perin, B. Canal, M. Boiocchi, Ann. Oncol. 5 (1994) 167 (https://doi.org/10.1093/oxfordjournals.annonc.a058771)

P. Das, D. Kotilingam, B. Korchin, J. Liu, D. Yu, A. J. Lazar, R. E. Pollock, D. Lev, Cancer 109 (2007) 2323 (https://doi.org/10.1002/cncr.22680)

L. Flanagan, M. Meyer, J. Fay, S. Curry, O. Bacon, H. Duessmann, K. John, K. C. Boland, D. A. McNamara, E. W. Kay, H. Bantel, H. Schulze-Bergkamen, J. H. Prehn, Cell Death Dis. 7 (2016) e2087 (https://doi.org/10.1038/cddis.2016.7)

N. O'Donovan, J. Crown, H. Stunell, A. D. Hill, E. McDermott, N. O'Higgins, M. J. Duffy, Clin. Cancer Res. 9 (2003) 738 (https://pubmed.ncbi.nlm.nih.gov/12576443/)

L. Nakopoulou, P. Alexandrou, K. Stefanaki, E. Panayotopoulou, A. C. Lazaris, P. S. Davaris, Pathobiology 69 (2001) 266 (https://doi.org/10.1159/000064337)

A. Nassar, D. Lawson, G. Cotsonis, C. Cohen, Appl. Immunohistochem. Mol. Morphol. (2008) 16 113 (https://doi.org/10.1097/PAI.0b013e318032ea73)

F. F. V. E. Silva, M. E. Padín-Iruegas, V. C. A. Caponio, A. I. Lorenzo-Pouso, P. Saavedra-Nieves, C. M. Chamorro-Petronacci, J. Suaréz-Peñaranda, M. Pérez-Sayáns, Int. J. Mol. Sci. 23 (2022) 11937 (https://doi.org/10.3390/ijms231911937)

R. Mohi-ud-din, A. Chawla, P. Sharma, Prince A. Mir, F. H. Potoo, Ž. Reiner, I. Reiner, D. A. Ateşşahin, J. Sharifi-Rad, R. H. Mir, D. Calina, Eur. J. Med. Res. 28 (2023) 345 (https://doi.org/10.1186/s40001-023-01275-4)

M. A. Hijazi, A. Gessner, N. El-Najjar, Cancers 15 (2023) 3199 (https://doi.org/10.3390/cancers15123199).